Pal Aishani, Sonowane Ruchi, Ramakrishna Wusirika
Department of Biochemistry, Central University of Punjab, VPO Ghudda, Punjab, 151401, India.
Mol Biotechnol. 2025 Aug 6. doi: 10.1007/s12033-025-01488-4.
Developing efficient medication delivery systems is a key area of research that will improve the efficacy of cancer treatments. As cancer cells have certain characteristics, it is crucial to precisely deliver chemotherapeutic drugs to the tumor microenvironment without harming healthy tissues. There has been a growing interest in exploiting biological agents to overcome the disadvantages of traditional cancer treatments in targeting and delivering drugs. These technologies utilize specific properties of the tumor microenvironment, such as the availability of excess glucose. This review discusses the current understanding of microrobots for cancer treatment with a special focus on bacteriobots. Bacteriobots are excellent candidates for smart cancer therapy because they can respond to particular cues from the tumor microenvironment. Similarly, microrobots include bacteriobots and other miniature materials/devices for the precise and specific targeting of cancer cells. Here, we discuss synthetic and biohybrid microrobots. It is imperative to make further technological advancements so that they can be employed on a large scale for cancer treatment.
开发高效的药物递送系统是一个关键的研究领域,它将提高癌症治疗的效果。由于癌细胞具有某些特性,在不损害健康组织的情况下将化疗药物精确递送至肿瘤微环境至关重要。利用生物制剂来克服传统癌症治疗在靶向和给药方面的缺点,这种兴趣日益浓厚。这些技术利用肿瘤微环境的特定特性,例如过量葡萄糖的可用性。本综述讨论了目前对用于癌症治疗的微型机器人的理解,特别关注细菌机器人。细菌机器人是智能癌症治疗的优秀候选者,因为它们可以对来自肿瘤微环境的特定信号做出反应。同样,微型机器人包括细菌机器人和其他用于精确和特异性靶向癌细胞的微型材料/装置。在这里,我们讨论合成微型机器人和生物杂交微型机器人。必须进一步取得技术进步,以便它们能够大规模用于癌症治疗。